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Purpose: Pterygium is an ocular surface disease of unknown etiology associated with epithelial and fibrovascular
outgrowth from the conjunctiva onto the cornea. S100 proteins are calcium-activated signaling proteins that interact with
other proteins to modulate biological functions such as cell migration, proliferation, and differentiation. The aim of this
study was to investigate the presence of various S100 proteins in pterygium compared to normal conjunctiva.
Methods: Immunofluorescent staining using antibodies against S100A4, S100A6, S100A8, S100A9, and S100A11 were
conducted to investigate the expression and tissue distribution. S100 protein secretions and expressions were confirmed
using western blot and quantitative real-time polymerase chain reaction (RT-PCR), respectively.
Results: Immunofluorescent staining demonstrated the presence of S100A4, S100A6, S100A8, S100A8, S100A9, and
S100A11 in both conjunctival and pterygial epithelium. No significant difference was found in the localization and
expression of S100A4. In both conjunctiva and pterygium, S100A4-positive cells were found in superficial and suprabasal
layers. S100A6 expression was strong in the superficial layer of pterygium epithelium but relatively weaker in the
suprabasal and superficial cells of normal conjunctiva epithelium. S100A8 and S100A9 were localized in the superficial
layer of both pterygium and normal conjunctiva epithelium, with higher levels in pterygium than uninvolved conjunctiva.
S100A11 was expressed in the basal cells of conjunctival epithelium but in the suprabasal layers of pterygium epithelium.
Western blot and RT–PCR confirmed the presence of S100A4, S100A6, S100A8, S100A9, and S100A11 in pterygium
and conjunctiva tissue.
Conclusions: Higher levels of S100A6, S100A8, and S100A9 expressions were detected in the pterygium tissue relative
to normal conjunctiva. In addition, a distinct alteration of localization of S100A11 expression was observed in pterygium
epithelium compared to the conjunctiva. Therefore, these S100 proteins may be associated with the formation of pterygium.
Pterygium  is  a  common  ocular  surface  disease
characterized by epithelial and fibrovascular outgrowth of
conjunctiva over the cornea. The wing-shaped epithelium of
pterygium  that  invades  the  cornea  centripetally  displays
squamous  metaplasia  and  goblet  cell  hyperplasia  [1].  On
many  occasions,  pterygium  can  impair  visual  function  in
instances such as irregular astigmatism or impaired tear film
regularity induced by pterygium and visual occlusion induced
by a large pterygium that has migrated to the visual axis over
the central cornea. Many etiologic factors have been described
for this disease. Compelling evidence that ultraviolet (UV)-
mediated limbal damage triggers this pathogenesis has been
studied  extensively  by  Coroneo  et  al.  [2,3].  Other  causes
include  an  anomaly  in  epidermal  proliferation  [4],
inflammation  [5],  stem  cell  dysfunction  [6],  changes  in
extracellular  matrix  [7],  metabolic  disorder  [8],  neuronal
dysfunction [9], and alterations in epithelial-mesenchymal
transition [10].
S100 proteins comprise a multitude of low molecular
weight,  calcium-binding  proteins  that  interact  with  other
proteins to modulate biological processes [11]. They have
been  named  S100  due  to  their  biochemical  property  of
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remaining soluble after precipitation with 100% ammonium
sulfate [12]. Thirteen members of the family are clustered
within  the  epidermal  differentiation  complex  located  on
chromosome 1q21 [13]. This region is of particular interest
because  it  encodes  genes  that  are  expressed  in  epidermal
keratinocytes  such  as  involucrin,  filaggrin,  repetin,  and
trichohyalin  [14],  which  are  also  expressed  on  the  ocular
surface [15]. S100 is characterized by the presence of two
calcium binding sites of the EF-hand type (helix–loop–helix),
one  of  which  is  located  in  the  NH2-terminal  and  is  non-
canonical while the other binding site is located in the COOH-
terminal and is canonical [16]. This configuration enables
S100 proteins to respond to a calcium stimulus induced by cell
signaling.
Possible S100 protein functions in keratinocytes have
been reviewed in a previous article [17]. One of them is acting
as a chemotactic agent. Kerkhoff et al. [18] have showed that
S100A8  and  S100A9  are  released  from  neutrophils  by  a
microtubule-dependent  mechanism  and  may  induce
inflammation  by  influencing  leukocyte  trafficking.  In
addition, S100A8 and S100A9 released from keratinocytes
may  initiate  immune  cell  invasion,  which  can  be  further
propagated  by  the  release  of  S100A8  and  S100A9  from
incoming neutrophils [19]. S100 proteins were proposed to
facilitate the membrane remodeling process as well, which is
evident by the interaction of S100A11 with membrane lipids
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335to  join  different  segments  of  the  membrane  or  bend  the
membrane  surface  [17].  S100A11  is  also  a  cross-linked
component  of  the  cornified  envelope,  a  structure  that  is
assembled  from  membrane-associated  constituents  [20].
Recently, S100A4, S100A6, S100A8, and S100A9 were also
shown to have potential roles in the wound healing mechanism
[19,21-23].  Chemotaxis,  tissue  remodeling  and  wound
healing defects, and anomaly in cornified envelope assembly
are some of the proposed mechanisms in pterygium formation
[1,9,15,24-26].The biological processes regulated by S100
proteins appear to be implicated in pterygium formation as
well. Therefore, we proceeded to investigate S100 expression
in pterygium. To the best of our knowledge, there has not been
a  study  on  the  expression  profile,  tissue  and  subcellular
localization,  and  function  of  S100  proteins  in  the  human
ocular surface and pterygium. Thus, we conducted a study to
investigate the pattern of expression of several S100 proteins
(S100A4,  S100A6,  S100A8,  S100A9,  and  S100A11)  in
uninvolved conjunctival and pterygium tissues. Our study also
aimed to identify the specific changes in the localization and
expression levels of the S100 proteins in pterygium relative
to the normal conjunctiva.
METHODS
Patients  and  specimens:  The  method  of  patient  specimen
collection was performed as previously described [27,28].
Briefly, the pterygium tissue from a patient was compared
with the uninvolved conjunctival tissue from the same eye that
was excised from the superior temporal quadrant of the bulbar
conjunctiva,  next  to  the  position  of  the  harvested  free
conjunctival  graft.  Paired  tissues  were  obtained  from  12
patients. All protocols adhered to the tenets of the Declaration
of Helsinki and were approved by the institutional review
board  of  the  Singapore  Eye  Research  Institute.  Written
informed  consents  were  acquired  from  all  participating
patients.
Materials  and  reagents:  Mouse  monoclonal  antibodies
against  S100A4,  S100A6,  S100A9,  and  S100A11  were
purchased  from  Abnova  (Taipei,  Taiwan),  and  mouse
monoclonal antibody against S100A8 from Acris Antibodies
(Hiddenhausen, Germany) was used. Goat anti-mouse HRP-
conjugated antibody, radio immunoprecipitation (RIPA) lysis
buffer,  and  UltraCruz  Mounting  Medium  containing  4.6-
diamidino-2-phenylindole  (DAPI)  were  purchased  from
Santa Cruz Biotechnology (Santa Cruz, CA). Goat anti-mouse
Alexa Fluor 488 was purchased from Invitrogen (Carlsbad,
California). The Universal ProbeLibrary set was from Roche
Applied Science (Mannheim, Germany). Stock PBS (10X)
was  purchased  from  1st  Base  (Singapore).  Bovine  serum
albumin  (BSA),  Tween-20,  and  Triton  X-100  were  from
Sigma (St. Louis, MO). Nitrocellulose membrane and non-fat
milk were purchased from Bio-Rad Laboratories (Hercules,
CA). Super Signal West Pico chemiluminescence reagent was
from Pierce Biotechnology (Rockford, IL).
Immunofluorescent  staining:  Conjunctival  tissues  from
normal conjunctival epithelium and pterygium were sectioned
with  a  Microm  HM550  cryostat  (Microm,  Walldorf,
Germany) at 6 μm thickness. Sections were fixed with ice-
cold acetone for 15 min, washed with 1X PBS, blocked with
4% BSA in 1X PBS containing 0.1% Triton X-100 (Sigma)
for 1 h, and then incubated with primary antibodies (Table 1)
diluted  in  the  blocking  solution  at  4  °C  overnight.  After
washing with 1X PBS, the sections were incubated with Alexa
Fluor  488-conjugated  secondary  antibody  at  room
temperature for 1 h. Slides were then mounted with UltraCruz
Mounting Medium. For negative controls, non-immune serum
was used in place of the specific primary antibody. Sections
were observed under and imaged with a Zeiss Axioplan 2
fluorescence microscope (Zeiss, Oberkochen, Germany).
TABLE 1. PRIMARY ANTIBODIES USED IN THE EXPERIMENT.
Dilution factor
IF WB
S100A4
 
Mouse monoclonal
(1F12–1G7)
Abnova 1/200 1/500
S100A6
 
Mouse monoclonal
(6B5)
Abnova 1/300 1/1000
S100A8
 
Mouse monoclonal
(8-5C2)
Acris Antibodies 1/150 1/1000
S100A9
 
Mouse monoclonal
(1C10)
Abnova 1/150 1/1000
S100A11
 
Mouse monoclonal
(2F4)
Abnova 1/150 1/1000
This table describes the primary antibodies used in the western blots and immunoflourescent staining experiments. The respective
animal  host, manufacturer, and dilution factor used in the experiments were displayed. IF, immunofluorescent staining; WB,
western blot.
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Target antigen Category (clone) ManufacturerWestern blot: Normal conjunctiva and pterygium tissue were
homogenized individually into RIPA lysis buffer. Insoluble
materials were removed by 15 min centrifugation (10,000x g)
at 4 °C. An equal volume of 4X SDS loading buffer was added
to each sample, which was then subjected to boiling for 5 min
at 99 °C. The sample was then left on ice for 10 min before
reduction on a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (15% SDS–PAGE gradient). The amounts of
protein  applied  was  60  µg.  Resolved  proteins  were
electrophoretically  transferred  onto  a  nitrocellulose
membrane and blocked in 1X PBS containing 5% non-fat milk
followed by overnight incubation with the primary antibody
(Table 1) at room temperature with agitation. The membranes
were then washed vigorously three times each for 5 min in 1X
PBS  and  0.1%  Tween-20.  The  goat  anti-mouse  HRP-
conjugated secondary antibody was then applied at a dilution
of  1:2000.  Immunoreactivity  was  visualized  with  Super
Signal West Pico chemiluminescence reagent.
Real-time polymerase chain reaction : Table 2 shows the
primers tested for the detection of various S100 transcripts.
Reverse transcription of 0.5 μg of RNA for each sample was
performed  as  previously  described  [15].  RT–polymerase
chain reaction (PCR) was performed by using the Lightcycler
480  System  (Roche  Diagnostics,  Basel,  Switzerland).  For
each  reaction,  the  appropriate  pre-synthesized  hydrolysis
FAM  (excitation  wavelength  of  483-533  nm)  probe  was
selected from the Universal ProbeLibrary set, based on the
ProbeFinder web-based assay design tool selecting for intron
spanning  assays.  Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as the internal control. For
each pair of primers and samples, triplicate wells were used.
ΔCt was calculated by subtracting the Ct of GAPDH from the
Ct of the targeted gene. The un-involved conjunctiva sample
was  considered  the  calibrator  to  compare  the  relative
abundance  of  each  tested  S100  gene  transcript  in  the
pterygium sample. The fold change was determined by the
equation,  2(-ΔΔCt),  where  ΔΔCt=ΔCtsample−ΔCtcalibrator.  A
probability  level  of  p<0.05  was  considered  statistically
significant.
RESULTS
S100 protein localization and expression:
Immunofluorescent  staining  detected  the  presence  of
S100A4, S100A6, S100A8, S100A9, and S100A11 in normal
human conjunctival and pterygium epithelia. No fluorescent
signals were detected in the negative controls (Figure 1A,B).
S100A4  expression  was  found  in  the  superficial  and
suprabasal layers of both the normal conjunctival (Figure 1C)
and  pterygium  (Figure  1D)  epithelia.  The  expression  was
localized  in  the  plasma  membrane  and  cytoplasm  of  the
superficial cells and in the membrane of the suprabasal cells
of both epithelia.
S100A6 was detected in the membrane and cytoplasm of
the superficial epithelial cells as well as some suprabasal cells
of normal conjunctival epithelium (Figure 1E) but was found
only in the superficial layer of pterygium epithelium (Figure
1F). A similar staining pattern was also observed with the
expression  of  S100A8  and  S100A9  in  the  uninvolved
conjunctiva  and  pterygium  (Figures  1G,I).  A  distinctly
different  expression  pattern  of  S100A11  was  noted  in
pterygium  epithelium  when  compared  to  the  uninvolved
conjunctiva. S100A11 was stained in the plasma membrane
TABLE 2. PRIMERS USED IN REAL-TIME PCR.
Gene NCBI accession number                              Primer sequence
S100A4
 
NM_002961.2 F: CGCTTCTTCTTTCTTGGTTTG
R: GAGTACTTGTGGAAGGTGGACA
S100A6
 
NM_014624.3 F: ACTGCGACACAGCCCATC
R: GAAGATGGCCACGAGGAG
S100A8
 
NM_002964.3 F: CAAGTCCGTGGGCATCAT
R: GACGTCGATGATAGAGTTCAAGG
S100A9
 
NM_002965.3 F: GTGCGAAAAGATCTGCAAAA
R: TCAGCTGCTTGTCTGCATTT
S100A11
 
NM_005620.1 F: TGAGGAGAGGCTCCAGACC
R: ACCGCTCAGTCTCTGTAGGG
GAPDH
 
AF261085.1
 
F: AGCCACATCGCTGAGACA
R: GCCCAATACGACCAAATCC
This table shows the various primers used against the S100 protein genes and GADPH   in the polymerase chain reactions. The
NCBI accession numbers of the sequences used to design the forward or 5' primer (F) and reverse or 3' primer (R) were shown,
in a 5' to 3' orientation.
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337of the basal layer of normal conjunctival epithelium (Figure
1K) while staining was more prominent in the suprabasal layer
of the pterygium tissue (Figure 1L).
Western blot (Figure 2) confirmed the presence of the
tested  S100  proteins  in  human  normal  conjunctiva  and
pterygium  tissue.  Immunoreactive  bands  corresponding  to
molecular  weight  of  approximately  11  kDa  showed  the
presence of S100A4, S100A6, and S100A11. Protein levels
of S100A4 and S100A11 in the pterygium tissue was not
significantly different compared with the normal conjunctiva.
However, expression of S100A6, S100A8, and S100A9 were
markedly greater in the pterygium tissue compared to the
uninvolved conjunctival tissue.
S100 transcript level: S100A4, S100A6, S100A8, S100A9, and
S100A11 gene transcripts were detected in conjunctiva and
pterygium tissues. Similar to the protein expression, S100A4
and S100A11 did not demonstrate any significant difference
in  expression  in  either  pterygium  or  conjunctival  tissues.
However,  S100A6,  S100A8,  and  S100A9  transcripts  were
upregulated  (p<0.05)  in  pterygium  relative  to  normal
Figure 1. Immunofluorescent staining of
S100  proteins  in  human  conjunctival
and  pterygial  epithelia.  Primary
antibodies against S100A4 (C and D),
S100A6 (E and F), S100A8 (G and H),
S100A9 (I and J), and S100A11 (K and
L) were used. Negative controls were
shown in A and B. Images of uninvolved
conjunctiva (A, C, E, G, I, and K) and
pterygium epithelium (B, D, F, H, J, and
L) were shown. The nuclei were stained
with  DAPI  present  in  the  mounting
medium.  A  dashed  line  indicates  the
location of the basement membrane. All
images  were  taken  at  400X
magnification.
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338Figure 2. Western blot analysis of S100 proteins expressed in human
conjunctiva and pterygium tissue. Uninvolved conjunctiva (Lane 1)
and pterygium (Lane 2) tissues were lysed in RIPA buffer and 60
μg  of  total  protein  was  loaded  in  each  lane  of  SDS-PAGE  and
transferred to nitrocellulose membrane and probed with antibodies
against various S100 proteins as well as β-actin (loading control).
Bands of 11 kDa corresponding to S100A4, S100A6, and S100A11
were detected. Bands corresponding to the molecular weight of 8
kDa and 13 kDa confirmed the presence of S100A8 and S100A9,
respectively.
conjunctiva.  This  result  corroborated  with  the  protein
expression. In pterygium tissue, S100A6 expression increased
2.30 fold, S100A8 increased 3.36 fold, and S100A9 increased
4.01  fold  relative  to  normal  conjunctiva.  A  bar  graph
summarizing the fold difference of these genes in pterygium
tissue  compared  to  the  conjunctiva  tissue  is  illustrated  in
Figure 3.
DISCUSSION
To the best of our knowledge, there have been no studies
describing the expression profiles of S100 proteins in the
normal  conjunctiva  and  diseases  associated  with  it.  Our
investigation  revealed  that  S100A4,  S100A6,  S100A8,
S100A9, and S100A11 are expressed in both the normal and
pterygium epithelia. The role of various S100 proteins has
been well documented in the normal skin epidermis and many
cutaneous  diseases  and  tumors  [17,29-33].  One  of  the
proposed causes for pathogenesis of pterygium is defective
cell differentiation [34]. Several studies have elucidated a role
for  S100  proteins  in  epithelial  differentiation  [14,35,36].
S100A8 and S100A9, which form homo- and heterodimers
and are frequently co-expressed [37], were shown in vivo and
in vitro to bind to keratin filaments [35,36]. Keratin proteins
are encoded by epidermal differentiation complex. Since these
proteins are expressed during terminal differentiation and are
associated with intermediate filaments, a functional role in the
reorganization of the cytoskeleton during hyperproliferative
ocular surface disease such as pterygium may be assumed for
S100A8  and  S100A9.  Our  findings,  which  showed  an
Figure 3. Fold difference of S100A4, S100A6, S100A8, S100A9, and
S100A11 gene transcripts in pterygium tissue relative to conjunctiva
tissue. Total RNA was extracted from uninvolved conjunctiva and
pterygium  tissue  after  mechanical  homogenization.  Reverse
transcription for 0.5 μg of total RNA. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as the internal control. ΔCt was
calculated by subtracting the Ct of GAPDH from the Ct of the targeted
gene. The fold change was determined by the ΔΔCt method (see text).
The uninvolved conjunctiva sample was used as a reference for each
of the tested S100 transcripts in the pterygium sample. Height of the
bars  represents  mean  value  and  error  bars  represent  standard
deviation. An asterisk indicates that p is less than 0.05 (p<0.05).
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339increased  expression  of  S100A8  and  S100A9  in  the
superficial layer of pterygium epithelium, support the notion
that S100 proteins are centrally involved in cell maturation
processes.
We  found  the  presence  of  S100A11  in  the  plasma
membrane of uninvolved human conjunctiva and pterygium
epithelial cells. This is consistent with the localization of
S100A11  in  the  cell  periphery  during  keratinocyte
differentiation  that  has  previously  been  described  in  vivo
[30] and in vitro [38]. As part of the differentiation process,
the individual S100A11 molecules have been known to be
covalently cross-linked to form the cornified envelope [20].
Menon  et  al.  [39]  reported  a  gradient  of  increasing  free
calcium  concentration  as  cells  move  from  the  basal  to
suprabasal layers during epidermal differentiation. A similar
pattern of alteration in the localization of S100A11 was seen
in our study, which further suggests that pterygium is related
to an anomaly in epithelial differentiation.
A complex model of S100A11 interaction with annexin
I has been proposed to explain the mechanism of action [40].
The S100A11/annexin I complex in the plasma membrane
creates  a  calcium  channel  that  permits  calcium  influx  in
terminally differentiated keratinocytes [40]. The increased
intracellular calcium may activate transglutaminase (TG) 1,
the enzyme responsible for the cornified envelope assembly
in stratified epithelium [8]. This relationship suggests that
S100A11 may function to facilitate membrane remodeling
during terminal differentiation in the ocular surface. Future
studies will investigate the colocalization and interactions of
S100A11, annexin I, and TG on the ocular surface.
Pterygium can be considered a wound healing defect
[10]. TG 2 has been known to play a crucial role in wound
healing, cell migration, apoptosis, and maintenance of ocular
surface  integrity  [41].  The  distribution  of  this  enzyme  in
pterygium has been investigated by Kim et al. [25]. Recently,
it was reported that S100A11 is also a TG 2 substrate [42]. In
addition,  S100A4  has  been  linked  with  corneal  fibroblast
regeneration [21] and S100A6 with the corneal wound healing
[22]. These findings suggest a potential role for S100 proteins
in  epithelial  wound  repair  and  response  to  stress  in  the
formation of pterygium.
Another process in pterygium pathogenesis is abnormal
fibrovascular and epithelial proliferation [4,7]. Pterygium has
traditionally  been  considered  a  chronic  degenerative
condition. However, it can also be regarded as a benign lesion
or tumor with abnormal p53 expression in the epithelium
[43]. S100A4 plays a role in metastasis and cell proliferation
and  has  been  implicated  in  the  development  of  epithelial
tumors  in  the  skin  [28,44,45].  However,  a  high  level  of
expression of these proteins was not found in other tumors,
e.g., malignant melanoma [46] and esophageal squamous cell
carcinoma [47]. Furthermore, we did not find any significant
change  in  expression  level  of  S100A4  in  the  pterygium
relative  to  the  conjunctiva,  consistent  with  the  lack  of
metastatic behavior in pterygium. Moreover, limbal stem cell
dysfunction was proposed as one of the causes of pterygium
[6]. Recently, Ito et al. [48] reported possible roles of S100A4
and S100A6 in the activation of stem cells at the onset of hair
follicle regeneration. The differential localization of S100A4
and S100A6 demonstrated in our study raises the possibility
of a stem cell defect in pterygium.
A limitation of this study was the small patient sample,
although the findings were highly reproducible within these
patients.  Another  limitation  was  that  the  uninvolved
conjunctiva was excised from the superior temporal quadrant
of the bulbar conjunctiva, next to the position of the harvested
conjunctiva graft. Although this is far away from the site of
pterygium, we accept that the conjunctiva may not be totally
normal.
Several family members of S100 proteins have been used
as  tumor  progression  markers  [49,50].  Recently,  our
laboratory detected a marked increase in the expression of
S100A8 and S100A9 in the tear fluid of pterygium patients
relative to the normal conjunctiva [51]. The findings in tissues
reported here suggest that tear analysis can possibly detect
pterygium progression. Therefore, possible detection of S100
protein levels may be useful as a clinical indicator for grading
the progression as well as severity of pterygium. It remains to
be  seen  whether  targeting  S100  proteins  can  help  in  the
treatment of pterygium.
In summary, a change in level of expression was detected
in S100A6, S100A8, and S100A9 in pterygium tissue relative
to the normal conjunctiva. In addition, distinct alteration of
the localization of S100A11 expression was observed in the
pterygium epithelium compared to the normal conjunctiva.
Therefore,  these  S100  proteins  may  be  associated  with
pterygium pathogenesis. Our current study will be followed
by an investigation of the functional implications of the S100
proteins  in  the  ocular  surface  as  well  as  their  roles  in
pterygium.
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